S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:LXRX

Lexicon Pharmaceuticals (LXRX) SEC Filings & 10K Form

$1.04
+0.02 (+1.96%)
(As of 10/3/2023 ET)
Compare
Today's Range
$0.96
▼
$1.04
50-Day Range
$1.02
▼
$2.01
52-Week Range
$0.96
▼
$3.79
Volume
2.51 million shs
Average Volume
1.45 million shs
Market Capitalization
$254.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Recent Lexicon Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
09/14/2023
4:05 PM		Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
6:07 AM		Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2023
6:09 AM		Lexicon Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2023
3:02 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
7:13 AM		Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2023
7:14 AM		Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:01 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
3:34 PM		Lexicon Pharmaceuticals (Subject)
Seth Kiernan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
3:13 PM		COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
3:20 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
3:22 PM		Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:04 PM		COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:30 PM		Lexicon Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/20/2023
3:10 PM		Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
3:46 PM		Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
3:31 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
8:08 PM		Lexicon Pharmaceuticals (Filer)
Form 424B5
06/01/2023
7:12 AM		Lexicon Pharmaceuticals (Subject)
Form FWP
05/31/2023
3:17 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
6:10 AM		Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2023
3:25 PM		Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
3:26 PM		Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2023
6:08 AM		Lexicon Pharmaceuticals (Filer)
Form DEF 14A
03/17/2023
6:10 AM		Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/03/2023
6:25 AM		Lexicon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2023
3:46 PM		COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
3:48 PM		Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
3:49 PM		Crum Brian T (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
3:50 PM		Granowitz Craig B (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
3:51 PM		Kassler-Taub Kenneth B. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2023
4:06 PM		Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2022
3:05 PM		Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:LXRX) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -